bioAffinity Technologies President and CEO Maria Zannes is attending the National Association of Veterans’ Research and Education Foundations’ (NAVREF) quarterly meeting of industry partners in Portland, OR, June 12-13.

NAVREF is a non-profit organization dedicated to advancing research and education focused on providing innovative, quality healthcare for military veterans. In addition to working with the Department of Veterans Affairs, NAVREF promotes research partnerships to improve veterans’ health. bioAffinity Technologies is a member of NAVREF’s Industry Partner Consortium.

bioAffinity Technologies is launching its first product, CyPath® Lung, a noninvasive, accurate sputum-based test for the early detection of lung cancer when it is most treatable.